Altered platelet calsequestrin abundance, Na⁺/Ca²⁺ exchange and Ca²⁺ signaling responses with the progression of diabetes mellitus.

[1]  D. Khananshvili,et al.  The SLC8 gene family of sodium-calcium exchangers (NCX) - structure, function, and regulation in health and disease. , 2013, Molecular aspects of medicine.

[2]  S. Watts,et al.  Reverse-mode Na+/Ca2+ exchange is an important mediator of venous contraction. , 2012, Pharmacological research.

[3]  F. Müller,et al.  Modulation of SR Ca2+ release by the triadin-to-calsequestrin ratio in ventricular myocytes. , 2012, American journal of physiology. Heart and circulatory physiology.

[4]  A. Zaman,et al.  Increased Atherothrombotic Burden in Patients with Diabetes Mellitus and Acute Coronary Syndrome: A Review of Antiplatelet Therapy , 2012, Cardiology research and practice.

[5]  Dali Luo,et al.  Potential regulatory role of calsequestrin in platelet Ca2+ homeostasis and its association with platelet hyperactivity in diabetes mellitus , 2012, Journal of thrombosis and haemostasis : JTH.

[6]  M. Nissen,et al.  Glycosylation of Skeletal Calsequestrin , 2011, The Journal of Biological Chemistry.

[7]  C. Reggiani,et al.  Massive alterations of sarcoplasmic reticulum free calcium in skeletal muscle fibers lacking calsequestrin revealed by a genetically encoded probe , 2010, Proceedings of the National Academy of Sciences.

[8]  Quanbin Zhang,et al.  Higher specificity of the activity of low molecular weight fucoidan for thrombin-induced platelet aggregation. , 2010, Thrombosis research.

[9]  M. Blaustein,et al.  Knockout of Na+/Ca2+ exchanger in smooth muscle attenuates vasoconstriction and L-type Ca2+ channel current and lowers blood pressure. , 2010, American journal of physiology. Heart and circulatory physiology.

[10]  M. Pulina,et al.  Orai1, a critical component of store-operated Ca2+ entry, is functionally associated with Na+/Ca2+ exchanger and plasma membrane Ca2+ pump in proliferating human arterial myocytes. , 2009, American journal of physiology. Cell physiology.

[11]  M. Gelderman,et al.  Carbon nanotubes activate blood platelets by inducing extracellular Ca2+ influx sensitive to calcium entry inhibitors. , 2009, Nano letters.

[12]  I. Russo,et al.  Platelet dysfunction in central obesity. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[13]  C. Reggiani,et al.  Anesthetic‐and heat‐induced sudden death in calsequestrin‐1‐knockout mice , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  P. Gisondi,et al.  Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors. , 2009, Seminars in thrombosis and hemostasis.

[15]  Daoyan Liu,et al.  High Glucose Enhances Transient Receptor Potential Channel Canonical Type 6–Dependent Calcium Influx in Human Platelets via Phosphatidylinositol 3-Kinase–Dependent Pathway , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[16]  R. Storey,et al.  Aspirin resistance and diabetes mellitus , 2008, Diabetologia.

[17]  S. Sage,et al.  A key role for reverse Na+/Ca2+ exchange influenced by the actin cytoskeleton in store-operated Ca2+ entry in human platelets: evidence against the de novo conformational coupling hypothesis. , 2007, Cell calcium.

[18]  R. Bobe,et al.  Platelet PMCA‐ and SERCA‐type Ca2+‐ATPase expression in diabetes: a novel signature of abnormal megakaryocytopoiesis , 2007, Journal of thrombosis and haemostasis : JTH.

[19]  Tao Yang,et al.  Modest Reductions of Cardiac Calsequestrin Increase Sarcoplasmic Reticulum Ca2+ Leak Independent of Luminal Ca2+ and Trigger Ventricular Arrhythmias in Mice , 2007, Circulation research.

[20]  Pin-Lan Li,et al.  Reconstitution and Characterization of a Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP)-sensitive Ca2+ Release Channel from Liver Lysosomes of Rats* , 2007, Journal of Biological Chemistry.

[21]  S. Cala,et al.  Different endoplasmic reticulum trafficking and processing pathways for calsequestrin (CSQ) and epitope-tagged CSQ. , 2006, Experimental cell research.

[22]  S. Steinhubl,et al.  Incidence and Prevention of Ischemic Stroke following Myocardial Infarction: Review of Current Literature , 2006, Cerebrovascular Diseases.

[23]  G. Salido,et al.  Two distinct Ca2+ compartments show differential sensitivity to thrombin, ADP and vasopressin in human platelets. , 2006, Cellular signalling.

[24]  S. Cala,et al.  Calsequestrin mutant D307H exhibits depressed binding to its protein targets and a depressed response to calcium. , 2004, Cardiovascular research.

[25]  K. Sipido,et al.  Sodium calcium exchange in the heart: necessity or luxury? , 2004, Circulation research.

[26]  G. Davı̀,et al.  Platelet activation in type 2 diabetes mellitus , 2004, Journal of thrombosis and haemostasis : JTH.

[27]  A. Mcnicol,et al.  Mechanism of Collagen Activation in Human Platelets* , 2004, Journal of Biological Chemistry.

[28]  A. Dulhunty,et al.  Calsequestrin and the calcium release channel of skeletal and cardiac muscle. , 2004, Progress in biophysics and molecular biology.

[29]  J. Rosado,et al.  The inositol trisphosphate receptor antagonist 2-aminoethoxydiphenylborate (2-APB) blocks Ca2+ entry channels in human platelets: cautions for its use in studying Ca2+ influx. , 2001, Cell calcium.

[30]  Y Li,et al.  Platelet hyperactivity and abnormal Ca(2+) homeostasis in diabetes mellitus. , 2001, American journal of physiology. Heart and circulatory physiology.

[31]  J. Putney,et al.  Signaling Pathways Underlying Muscarinic Receptor-induced [Ca2+] i Oscillations in HEK293 Cells* , 2001, The Journal of Biological Chemistry.

[32]  J. Sotelo,et al.  Calcium efflux from platelet vesicles of the dense tubular system. Analysis of the possible contribution of the Ca2+ pump , 1999, Molecular and Cellular Biochemistry.

[33]  L. Mazzanti,et al.  Altered Platelet Membrane Dynamic Properties in Type 1 Diabetes , 1997, Diabetes.

[34]  Á. Enyedi,et al.  Demonstration of two distinct calcium pumps in human platelet membrane vesicles. , 1986, The Journal of biological chemistry.

[35]  K. Badenhoop,et al.  Platelet Sarcoplasmic Endoplasmic Reticulum Ca2+-ATPase and &mgr;-Calpain Activity Are Altered in Type 2 Diabetes Mellitus and Restored by Rosiglitazone , 2008, Circulation.

[36]  Andreas Schober,et al.  Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E , 2003, Nature Medicine.